Atlas Trials

Study To Evaluate Safety And Tolerability Of Pegaptanib Sodium In Patients With Diabetic Macular Edema

Clinical trial NCT01189461 · COMPLETED

Trial details

NCT number
NCT01189461
Sponsor
Pfizer
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Anti- VGF InhibitorDiabetic Macular EdemaDiabetic Retinopathy
Start date
2011-01-01
Primary completion
2012-07-01
Enrollment
46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.